These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17095032)

  • 21. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
    Popik W; Alce TM; Au WC
    J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.
    Kozak SL; Heard JM; Kabat D
    J Virol; 2002 Feb; 76(4):1802-15. PubMed ID: 11799176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
    Ono A; Demirov D; Freed EO
    J Virol; 2000 Jun; 74(11):5142-50. PubMed ID: 10799589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization.
    Salimi H; Johnson J; Flores MG; Zhang MS; O'Malley Y; Houtman JC; Schlievert PM; Haim H
    J Biol Chem; 2020 Jan; 295(2):348-362. PubMed ID: 31757809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.
    Barros M; Heinrich F; Datta SAK; Rein A; Karageorgos I; Nanda H; Lösche M
    J Virol; 2016 May; 90(9):4544-4555. PubMed ID: 26912608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the alpha-helix directly C-terminal to the major homology region of human immunodeficiency virus type 1 capsid protein disrupt Gag multimerization and markedly impair virus particle production.
    Chu HH; Chang YF; Wang CT
    J Biomed Sci; 2006 Sep; 13(5):645-56. PubMed ID: 16770689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions.
    Perez-Caballero D; Hatziioannou T; Martin-Serrano J; Bieniasz PD
    J Virol; 2004 Sep; 78(17):9560-3. PubMed ID: 15308748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
    Ono A; Orenstein JM; Freed EO
    J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitination of human immunodeficiency virus type 1 Gag is highly dependent on Gag membrane association.
    Jäger S; Gottwein E; Kräusslich HG
    J Virol; 2007 Sep; 81(17):9193-201. PubMed ID: 17609272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag.
    Nitta T; Tam R; Kim JW; Fan H
    mBio; 2011; 2(1):e00341-10. PubMed ID: 21343359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1.
    Milev MP; Brown CM; Mouland AJ
    Retrovirology; 2010 May; 7():41. PubMed ID: 20459747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane.
    Ono A; Ablan SD; Lockett SJ; Nagashima K; Freed EO
    Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14889-94. PubMed ID: 15465916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts.
    Graham DR; Chertova E; Hilburn JM; Arthur LO; Hildreth JE
    J Virol; 2003 Aug; 77(15):8237-48. PubMed ID: 12857892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release.
    Lee YH; Schwartz MD; Panganiban AT
    Virology; 1997 Oct; 237(1):46-55. PubMed ID: 9344906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palmitoylated Cysteines in Chikungunya Virus nsP1 Are Critical for Targeting to Cholesterol-Rich Plasma Membrane Microdomains with Functional Consequences for Viral Genome Replication.
    Bakhache W; Neyret A; Bernard E; Merits A; Briant L
    J Virol; 2020 May; 94(10):. PubMed ID: 32132240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag.
    Guo X; Roldan A; Hu J; Wainberg MA; Liang C
    J Virol; 2005 Feb; 79(3):1803-12. PubMed ID: 15650204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions.
    Scarlata S; Ehrlich LS; Carter CA
    J Mol Biol; 1998 Mar; 277(2):161-9. PubMed ID: 9514761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2.
    Batonick M; Favre M; Boge M; Spearman P; Höning S; Thali M
    Virology; 2005 Nov; 342(2):190-200. PubMed ID: 16139856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity.
    Jolly C; Sattentau QJ
    J Virol; 2005 Sep; 79(18):12088-94. PubMed ID: 16140785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
    Demirov DG; Orenstein JM; Freed EO
    J Virol; 2002 Jan; 76(1):105-17. PubMed ID: 11739676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.